Short Term Outcomes of a Dedicated Balloon Expandable Bridging Stent in Branched Endovascular Aortic Aneurysm Repair.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41475432.
- Also identified by DOI 10.1016/j.ejvs.2025.12.049.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aimed to report the short term outcomes of the BeGraft Peripheral Plus (BGP+) bridging stent graft following branched endovascular aortic repair (BEVAR) of thoraco-abdominal and complex abdominal aortic aneurysms. All consecutive patients treated in six high-volume centers with BEVAR incorporating at least one branch for the renovisceral arteries (outer branches) and who received at least one BGP+ as a bridging stent graft were included and data retrospectively analyzed. A total of 2 418 target visceral vessels in 729 patients undergoing BEVAR were bridged with a BGP+. Technical success was achieved in 99.3% of branches. The median follow up was 17 months (interquartile range 10, 35 months). The estimated 1 and 2 year branch primary patency was 98.3% (standard error [SE] 0.3) and 95.8% (SE 0.7), respectively, with a total of 56 occlusions. The estimated 1 and 2 year branch secondary patency was 99.2% (SE 0.2) and 98.4% (SE 0.3), respectively. The target vessel instability rate was 2.9%, with seven type Ic endoleaks (T1cELs), one type 3b EL, and two type 3c ELs. The overall 30 day mortality rate was 6.0%. Additional unplanned stents were deployed in 268 of 2 418 target visceral vessels owing to vessel dissection (n = 4), need for extended seal (n = 185), vessel angulation (n = 73), vessel perforation (n = 5), or T1cEL (n = 1). The estimated 1 and 2 year freedom from branch related re-intervention was 99.3% (SE 0.2) and 98.4% (SE 0.3), respectively. BEVAR performed with BGP+ bridging stents is associated with very satisfactory short term outcomes. Longer follow up is required to confirm these promising results.